BRCA2 Deficiency Unlocks New Cancer Vulnerability Pathway
Groundbreaking research uncovers a previously unknown mechanism by which BRCA2-deficient cancer cells accumulate uracil in single-stranded DNA. This discovery reveals a critical vulnerability that could be exploited for targeted cancer therapies.
